Hanimune Therapeutics

What Hanimune Therapeutics does

Hanimune Therapeutics is a Philadelphia-based, commercial-stage biotechnology company founded in 2018 that develops consumer food products for the prevention and treatment of food allergies. The company's portfolio consists of two wholly-owned brands: Lil Mixins, early allergen introduction powders that enable parents to add peanut, egg, and other common allergens to infant diets starting at 4-6 months of age, with each serving delivering a precise two-gram dose of each allergen in line with the 2017 NIAID prevention guidelines; and Top9Proteins, foods engineered with reliable allergen quantities and allergenicity to support tolerance development at any age. The underlying technology is centered on food protein function, sourcing, and processing, applied through what the company describes as decades of experience in food science.

Name

Hanimune Therapeutics

Legal name

Hanimune Therapeutics

Website

https://hanimunetherapeutics.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

Hanimune Therapeutics is a commercial-stage biotech that sells Lil Mixins early allergen introduction powders for infants and Top9Proteins tolerance foods for any age, serving parents, patients, and healthcare providers in the United States to prevent and treat food allergies.

Ownership category

akta.pro rank

Product category

Pediatric Food Allergy Prevention / Infant Nutrition

NAICS

Food (Health) Supplement Retailers (456191)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Baby Nutrition for Special Diets (Gluten-Free, Kosher/Halal, Allergen-Controlled) (CRADAEAO)

akta.pro secondary industries

Baby Snacks (Puffs, Biscuits, Teething Snacks) (CRADAEAF), Children’s Vitamins & Supplements (CRADAGAJ), “Free-From” & Allergen-Free Claim Substantiation (e.g., gluten-free, peanut-free) (AFALAHAD), Pediatric OTC Medicines (HLAIADAL)

Keywords

• Food allergy prevention
• Early allergen introduction
• Infant nutrition products
• Allergy tolerance foods
• Pediatric allergen supplements

Headquarters

HQ city

Philadelphia

HQ country

United States

HQ region

North America

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Consumer Product Sales: Sale of consumer products including Lil Mixins early allergen introduction powders and Top9Proteins foods sold through retail (Target) and direct-to-consumer e-commerce channels.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Hanimune Therapeutics develops and sells consumer food products designed to prevent and treat food allergies through early allergen introduction. Its Lil Mixins brand offers powdered supplements for infants (starting at 4-6 months) that allow parents to add individual common allergens (peanut, egg, and others) at the precise 2-gram dosage recommended in the 2017 NIAID prevention guidelines. Its Top9Proteins brand provides foods with reliable allergen quantities and allergenicity to support tolerance development at any age.

Product overview

Hanimune Therapeutics is a commercial-stage therapeutics company offering two distinct consumer product lines for food allergy prevention and tolerance support. Lil Mixins provides early allergen introduction powders for infants (4-6 months and up), enabling parents to add common allergens early and often per clinical guidelines. Top9Proteins creates foods with reliable allergen quantities and allergenicity designed to support tolerance development at any age. Both products are sold direct-to-consumer and through retail partners like Target, addressing the needs of 33 million Americans with food allergies.

Differentiator

Problem solved

Functional benefit

Brands

• Lil Mixins: Consumer product line of early allergen introduction powders making it easy for parents to add common allergens into infant diets early and often. The only brand providing options to consume each early allergen individually and providing two grams of each allergen per serving.
• Top9Proteins

Products and services

• Lil Mixins Early Allergen Introduction Powders Early allergen introduction powders that make it easy for parents to add common allergens (peanut, egg, and other common allergens) into infant diets early and often. The only brand providing options to consume each early allergen individually and the only brand to provide two grams of each allergen per serving, both essential elements of 2017 NIAID prevention guidance. Targeted at parents of infants starting at 4-6 months of age.
• Top9Proteins Tolerance-Supporting Foods Creates foods with reliable quantities and allergenicity to support food allergy tolerance at any age. Designed for doctors and patients seeking better options to support tolerance development beyond early allergen introduction.

Quantifiable outcome

• 36% reduction in food allergies in children under three; 43% drop in peanut allergies attributed to adoption of 2017 early allergen introduction guidelines
• +1 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Emerging players

• DBV Technologies: Clinical-stage biopharmaceutical company developing Viaskin epicutaneous immunotherapy patches for peanut and other food allergies. Operates in the same food allergy space as Hanimune but focuses on treatment rather than prevention via foods.
• Cerebelly: Clean-label baby food brand founded by a pediatric neurosurgeon emphasizing nutrition for early brain development. Comparable as a science-led, DTC + retail infant nutrition brand targeting health-conscious parents — overlaps on category and customer but not directly on allergen introduction.
• ELSE Nutrition: Plant-based infant and toddler nutrition company offering dairy-free alternatives. Comparable as a smaller, mission-driven baby nutrition brand pursuing retail distribution in the US; complementary rather than direct overlap with Lil Mixins.
• Bobbie: Modern, direct-to-consumer infant formula brand emphasizing clean ingredients and pediatrician credibility. Comparable in channel strategy (DTC + retail), target customer (parents of infants), and food-as-medicine positioning even though the product category is formula rather than allergen introduction.

Broad incumbents

• Gerber (Nestlé Infant Nutrition): Largest incumbent in US baby food and infant nutrition, owned by Nestlé. Competes with Lil Mixins on shelf space at retailers like Target and could enter the early allergen introduction category with significant distribution and marketing scale.
• Earth's Best (Hain Celestial): Established organic infant food brand sold across grocery and mass channels. Adjacent competitor on early allergen introduction ingredient claims (e.g., baby cereals) and represents the kind of incumbent that could accelerate into Hanimune's category with shelf scale.
• Aimmune Therapeutics (Nestlé Health Science): Developer of Palforzia, the first FDA-approved oral immunotherapy for peanut allergy, now owned by Nestlé Health Science. Addresses the same food allergy patient population as Hanimune but on the treatment side rather than prevention, and part of a much broader nutrition and therapeutics portfolio.
• Happy Family Organics (Nestlé): Premium organic baby food brand (HappyBaby, HappyTot) now under Nestlé. Competes with Lil Mixins on grocery shelf real estate and illustrates how large incumbents have consolidated premium infant nutrition — a potential threat to Hanimune's category-defining positioning.

Direct peers

• Ready, Set, Food!: Direct competitor offering early allergen introduction systems for infants, including a powder format added to baby food. Targets the same parent persona and allergen-introduction use case as Lil Mixins.
• Mission MightyMe: Direct competitor in the early allergen introduction category. Mission MightyMe (formerly SpoonfulONE) sells peanut and multi-allergen puffs marketed to parents for early introduction in infants, overlapping directly with Hanimune's Lil Mixins positioning and target customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries2 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hanimune Therapeutics